-
A Phase I Open-Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26–104/RFASE in Patients with Advanced Solid Malignancies
Goedegebuure, R. S. A., Wentink, M. Q., van der Vliet, H. J., Timmerman, P., Griffioen, A. W., de Gruijl, T. D. & Verheul, H. M. W., Feb 2021, In: oncologist. 26, 2, p. e218-e229Research output: Contribution to journal › Article › Academic › peer-review
-
Immunotherapy and combined treatment approaches to angiogenesis inhibition
Wentink, M. Q., 2019, 224 p.Research output: PhD Thesis › Phd-Thesis - Research and graduation internal
-
A safety and immunogenicity study of immunization with hVEGF/RFASE in cynomolgus monkeys
Wentink, M. Q., Verheul, H. M. W., Griffioen, A. W., Schafer, K. A., McPherson, S., Early, R. J., van der Vliet, H. J. & de Gruijl, T. D., 5 Apr 2018, In: Vaccine. 36, 15, p. 2025-2032 8 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
